Search result for miRNA = '' Or
cancer = 'prostate cancer' Total: 271
relations found.
hsa-let-7a-3p |
|
prostate cancer |
down |
The miRNA let-7a1 inhibits the expression of insulin-like growth factor 1 receptor (IGF1R) in prostate cancer PC-3 cells. |
hsa-let-7c |
|
prostate cancer |
down |
MicroRNA let-7c suppresses androgen receptor expression and activity via regulation of Myc expression in prostate cancer cells. |
hsa-let-7c |
|
prostate cancer |
down |
MicroRNA let-7c is downregulated in prostate cancer and suppresses prostate cancer growth. |
hsa-miR-100 |
|
prostate cancer |
down |
Loss of miR-100 enhances migration, invasion, epithelial-mesenchymal transition and stemness properties in prostate cancer cells through targeting Argonaute 2. |
hsa-miR-101 |
|
prostate cancer |
down |
Enforced expression of miR-101 inhibits prostate cancer cell growth by modulating the COX-2 pathway in vivo. |
hsa-miR-105 |
|
prostate cancer |
down |
miR-105 Inhibits Prostate Tumour Growth by Suppressing CDK6 Levels. |
hsa-miR-124 |
|
prostate cancer |
down |
MiR-124 suppresses cell motility and adhesion by targeting talin 1 in prostate cancer cells. |
hsa-miR-125b |
|
prostate cancer |
up |
Widespread deregulation of microRNA expression in human prostate cancer. |
hsa-miR-125b |
|
prostate cancer |
up |
Oncomir miR-125b suppresses p14(ARF) to modulate p53-dependent and p53-independent apoptosis in prostate cancer. |
hsa-miR-128 |
|
prostate cancer |
down |
MicroRNA-128 downregulates Bax and induces apoptosis in human embryonic kidney cells. |
hsa-miR-128 |
|
prostate cancer |
down |
miRNA-128 suppresses prostate cancer by inhibiting BMI-1 to inhibit tumor-initiating cells. |
hsa-miR-1296 |
|
prostate cancer |
down |
Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer. |
hsa-miR-130b |
|
prostate cancer |
down |
MiR-130b suppresses prostate cancer metastasis through down-regulation of MMP2. |
hsa-miR-133b |
mir-133 |
prostate cancer |
down |
microRNA-133 inhibits cell proliferation, migration and invasion in prostate cancer cells by targeting the epidermal growth factor receptor. |
hsa-miR-135a |
|
prostate cancer |
down |
Androgen-regulated microRNA-135a decreases prostate cancer cell migration and invasion through downregulating ROCK1 and ROCK2. |
hsa-miR-141 |
|
prostate cancer |
up |
A study of molecular signals deregulating mismatch repair genes in prostate cancer compared to benign prostatic hyperplasia. |
hsa-miR-143 |
|
prostate cancer |
down |
miR-143 interferes with ERK5 signaling, and abrogates prostate cancer progression in mice. |
hsa-miR-143 |
|
prostate cancer |
down |
miR-143 decreases prostate cancer cells proliferation and migration and enhances their sensitivity to docetaxel through suppression of KRAS. |
hsa-miR-143 |
|
prostate cancer |
down |
MicroRNA-143 inhibits cell migration and invasion by targeting matrix metalloproteinase 13 in prostate cancer. |
hsa-miR-143 |
|
prostate cancer |
down |
The tumor-suppressive microRNA-143/145 cluster inhibits cell migration and invasion by targeting GOLM1 in prostate cancer. |
hsa-miR-145 |
|
prostate cancer |
down |
The functional significance of microRNA-145 in prostate cancer. |
hsa-miR-145 |
|
prostate cancer |
down |
Restoration of miR-145 expression suppresses cell proliferation, migration and invasion in prostate cancer by targeting FSCN1. |
hsa-miR-145 |
|
prostate cancer |
down |
MicroRNA-145 is regulated by DNA methylation and p53 gene mutation in prostate cancer. |
hsa-miR-145 |
|
prostate cancer |
down |
The tumor-suppressive microRNA-143/145 cluster inhibits cell migration and invasion by targeting GOLM1 in prostate cancer. |
hsa-miR-145 |
|
prostate cancer |
down |
miR-145 suppress the androgen receptor in prostate cancer cells and correlates to prostate cancer prognosis. |
hsa-miR-146a |
|
prostate cancer |
down |
Clinical significance of miR-146a in gastric cancer cases. |
hsa-miR-146a |
|
prostate cancer |
down |
miR-146a functions as a tumor suppressor in prostate cancer by targeting Rac1. |
hsa-miR-153 |
|
prostate cancer |
up |
Upregulation of miR-153 promotes cell proliferation via downregulation of the PTEN tumor suppressor gene in human prostate cancer. |
hsa-miR-154 |
|
prostate cancer |
down |
miR-154 inhibits prostate cancer cell proliferation by targeting CCND2. |
hsa-miR-155 |
|
prostate cancer |
up |
A study of molecular signals deregulating mismatch repair genes in prostate cancer compared to benign prostatic hyperplasia. |
hsa-miR-15a |
|
prostate cancer |
down |
Downregulation of miR-221, -30d, and -15a contributes to pathogenesis of prostate cancer by targeting Bmi-1. |
hsa-miR-15a |
mir-15 |
prostate cancer |
down |
A microRNA code for prostate cancer metastasis. |
hsa-miR-15b |
mir-15 |
prostate cancer |
down |
A microRNA code for prostate cancer metastasis. |
hsa-miR-16 |
|
prostate cancer |
down |
A microRNA code for prostate cancer metastasis. |
hsa-miR-181b |
|
prostate cancer |
up |
MicroRNA-181b expression in prostate cancer tissues and its influence on the biological behavior of the prostate cancer cell line PC-3. |
hsa-miR-181c |
mir-181 |
prostate cancer |
up |
microRNA-181 promotes prostate cancer cell proliferation by regulating DAX-1 expression. |
hsa-miR-181d |
mir-181 |
prostate cancer |
up |
microRNA-181 promotes prostate cancer cell proliferation by regulating DAX-1 expression. |
hsa-miR-182 |
|
prostate cancer |
up |
miR-183-96-182 cluster is overexpressed in prostate tissue and regulates zinc homeostasis in prostate cells. |
hsa-miR-182 |
|
prostate cancer |
up |
Overexpressed microRNA-182 promotes proliferation and invasion in prostate cancer PC-3 cells by down-regulating N-myc downstream regulated gene 1 (NDRG1). |
hsa-miR-182 |
|
prostate cancer |
up |
Hypoxia-inducible miR-182 enhances HIF1? signaling via targeting PHD2 and FIH1 in prostate cancer. |
hsa-miR-182-5p |
|
prostate cancer |
up |
MicroRNA-182-5p Promotes Cell Invasion and Proliferation by Down Regulating FOXF2, RECK and MTSS1 Genes in Human Prostate Cancer. |
hsa-miR-183 |
|
prostate cancer |
up |
miR-183-96-182 cluster is overexpressed in prostate tissue and regulates zinc homeostasis in prostate cells. |
hsa-miR-183 |
|
prostate cancer |
up |
microRNA-183 is an oncogene targeting Dkk-3 and SMAD4 in prostate cancer. |
hsa-miR-187 |
|
prostate cancer |
down |
MiR-187 Targets the Androgen-Regulated Gene ALDH1A3 in Prostate Cancer. |
hsa-miR-188-5p |
|
prostate cancer |
down |
miR-188-5p inhibits tumour growth and metastasis in prostate cancer by repressing LAPTM4B expression. |
hsa-miR-18a |
|
prostate cancer |
up |
MicroRNA-18a is elevated in prostate cancer and promotes tumorigenesis through suppressing STK4 in vitro and in vivo. |
hsa-miR-195 |
mir-15 |
prostate cancer |
down |
A microRNA code for prostate cancer metastasis. |
hsa-miR-195 |
|
prostate cancer |
down |
miR-195 Inhibits Tumor Progression by Targeting RPS6KB1 in Human Prostate Cancer. |
hsa-miR-199b |
|
prostate cancer |
down |
MiR199b Suppresses Expression of Hypoxia-Inducible Factor 1? (HIF-1?) in Prostate Cancer Cells. |
hsa-miR-200b |
|
prostate cancer |
down |
miR-200b suppresses cell proliferation, migration and enhances chemosensitivity in prostate cancer by regulating Bmi-1. |
hsa-miR-200b |
|
prostate cancer |
down |
miR-200b inhibits prostate cancer EMT, growth and metastasis. |
hsa-miR-203 |
|
prostate cancer |
down |
Loss of EGFR signaling regulated miR-203 promotes prostate cancer bone metastasis and tyrosine kinase inhibitors resistance. |
hsa-miR-203 |
|
prostate cancer |
down |
MiR-203 down-regulates Rap1A and suppresses cell proliferation, adhesion and invasion in prostate cancer. |
hsa-miR-204 |
|
prostate cancer |
up |
Mechanisms and functional consequences of PDEF protein expression loss during prostate cancer progression. |
hsa-miR-205 |
|
prostate cancer |
down |
Downregulation of miR-205 and miR-31 confers resistance to chemotherapy-induced apoptosis in prostate cancer cells. |
hsa-miR-205 |
|
prostate cancer |
down |
Epigenetic-induced repression of microRNA-205 is associated with MED1 activation and a poorer prognosis in localized prostate cancer. |
hsa-miR-205 |
|
prostate cancer |
down |
MicroRNA-205, a novel regulator of the anti-apoptotic protein Bcl2, is downregulated in prostate cancer. |
hsa-miR-205 |
|
prostate cancer |
down |
miR-205 is frequently downregulated in prostate cancer and acts as a tumor suppressor by inhibiting tumor growth. |
hsa-miR-205 |
|
prostate cancer |
down |
Polycomb protein EZH2 suppresses apoptosis by silencing the proapoptotic miR-31. |
hsa-miR-205 |
|
prostate cancer |
down |
MicroRNA-205 inhibits cancer cell migration and invasion via modulation of centromere protein F regulating pathways in prostate cancer. |
hsa-miR-205 |
|
prostate cancer |
down |
Editorial Comment to MicroRNA-205 inhibits cancer cell migration and invasion via modulation of centromere protein F regulating pathways in prostate cancer. |
hsa-miR-20a |
|
prostate cancer |
up |
miR-20a promotes Prostate cancer invasion and migration through targeting ABL2. |
hsa-miR-21 |
|
prostate cancer |
up |
MicroRNA-21 inhibits p57Kip2 expression in prostate cancer. |
hsa-miR-21 |
|
prostate cancer |
up |
A study of molecular signals deregulating mismatch repair genes in prostate cancer compared to benign prostatic hyperplasia. |
hsa-miR-21 |
|
prostate cancer |
up |
A microRNA code for prostate cancer metastasis. |
hsa-miR-212 |
|
prostate cancer |
down |
A potential regulatory loop between Lin28B:miR?212 in androgen-independent prostate cancer. |
hsa-miR-218 |
|
prostate cancer |
down |
Tumor-suppressive microRNA-218 inhibits cancer cell migration and invasion via targeting of LASP1 in prostate cancer. |
hsa-miR-218 |
|
prostate cancer |
down |
microRNA-218 inhibits prostate cancer cell growth and promotes apoptosis by repressing TPD52 expression. |
hsa-miR-221 |
|
prostate cancer |
up |
MiR-221 promotes the development of androgen independence in prostate cancer cells via downregulation of HECTD2 and RAB1A. |
hsa-miR-221 |
|
prostate cancer |
down |
Downregulation of miR-221, -30d, and -15a contributes to pathogenesis of prostate cancer by targeting Bmi-1. |
hsa-miR-221 |
|
prostate cancer |
up |
Effects of microRNA-221/222 on cell proliferation and apoptosis in prostate cancer cells. |
hsa-miR-221 |
|
prostate cancer |
down |
MicroRNA expression signature of castration-resistant prostate cancer: the microRNA-221/222 cluster functions as a tumour suppressor and disease progression marker. |
hsa-miR-222 |
|
prostate cancer |
up |
Effects of microRNA-221/222 on cell proliferation and apoptosis in prostate cancer cells. |
hsa-miR-222 |
|
prostate cancer |
down |
MicroRNA expression signature of castration-resistant prostate cancer: the microRNA-221/222 cluster functions as a tumour suppressor and disease progression marker. |
hsa-miR-223-3p |
|
prostate cancer |
up |
MiR-223-3p targeting SEPT6 promotes the biological behavior of prostate cancer. |
hsa-miR-224 |
|
prostate cancer |
down |
MicroRNA-224 inhibits progression of human prostate cancer by downregulating TRIB1. |
hsa-miR-224 |
|
prostate cancer |
down |
Tumour-suppressive microRNA-224 inhibits cancer cell migration and invasion via targeting oncogenic TPD52 in prostate cancer. |
hsa-miR-224 |
|
prostate cancer |
down |
MicroRNA-224 and its target CAMKK2 synergistically influence tumor progression and patient prognosis in prostate cancer. |
hsa-miR-23a |
|
prostate cancer |
down |
Downregulation of microRNA-23a suppresses prostate cancer metastasis by targeting the PAK6-LIMK1 signaling pathway. |
hsa-miR-23b |
|
prostate cancer |
down |
miR-23b represses proto-oncogene Src kinase and functions as methylation-silenced tumor suppressor with diagnostic and prognostic significance in prostate cancer. |
hsa-miR-25 |
|
prostate cancer |
down |
miR-25 Modulates Invasiveness and Dissemination of Human Prostate Cancer Cells via Regulation of ?v- and ?6-Integrin Expression. |
hsa-miR-26a |
|
prostate cancer |
down |
Myc enforces overexpression of EZH2 in early prostatic neoplasia via transcriptional and post-transcriptional mechanisms. |
hsa-miR-26a |
|
prostate cancer |
down |
MiR-26a inhibits prostate cancer progression by repression of Wnt5a. |
hsa-miR-26b |
|
prostate cancer |
down |
Myc enforces overexpression of EZH2 in early prostatic neoplasia via transcriptional and post-transcriptional mechanisms. |
hsa-miR-29b |
|
prostate cancer |
down |
miRNA-29b suppresses prostate cancer metastasis by regulating epithelial-mesenchymal transition signaling. |
hsa-miR-302a |
|
prostate cancer |
down |
MicroRNA-302a Suppresses Tumor Cell Proliferation by Inhibiting AKT in Prostate Cancer. |
hsa-miR-30a |
mir-30 |
prostate cancer |
down |
miR-30 as a tumor suppressor connects EGF/Src signal to ERG and EMT. |
hsa-miR-30b |
mir-30 |
prostate cancer |
down |
miR-30 as a tumor suppressor connects EGF/Src signal to ERG and EMT. |
hsa-miR-30d |
mir-30 |
prostate cancer |
down |
miR-30 as a tumor suppressor connects EGF/Src signal to ERG and EMT. |
hsa-miR-30d |
|
prostate cancer |
down |
Downregulation of miR-221, -30d, and -15a contributes to pathogenesis of prostate cancer by targeting Bmi-1. |
hsa-miR-30e |
mir-30 |
prostate cancer |
down |
miR-30 as a tumor suppressor connects EGF/Src signal to ERG and EMT. |
hsa-miR-31 |
|
prostate cancer |
down |
Downregulation of miR-205 and miR-31 confers resistance to chemotherapy-induced apoptosis in prostate cancer cells. |
hsa-miR-31 |
|
prostate cancer |
up |
Screening Biomarkers of Prostate Cancer by Integrating microRNA and mRNA Microarrays. |
hsa-miR-31 |
|
prostate cancer |
down |
Polycomb protein EZH2 suppresses apoptosis by silencing the proapoptotic miR-31. |
hsa-miR-323 |
|
prostate cancer |
down |
MiR-323 Inhibits Prostate Cancer Vascularization Through Adiponectin Receptor. |
hsa-miR-330 |
|
prostate cancer |
down |
MicroRNA-330 acts as tumor suppressor and induces apoptosis of prostate cancer cells through E2F1-mediated suppression of Akt phosphorylation. |
hsa-miR-330 |
|
prostate cancer |
down |
microRNA-330 inhibits cell motility by downregulating Sp1 in prostate cancer cells. |
hsa-miR-331-3p |
|
prostate cancer |
down |
miR-331-3p regulates ERBB-2 expression and androgen receptor signaling in prostate cancer. |
hsa-miR-331-3p |
|
prostate cancer |
down |
Regulation of Expression of Deoxyhypusine Hydroxylase (DOHH), the Enzyme That Catalyzes the Activation of eIF5A, by miR-331-3p and miR-642-5p in Prostate Cancer Cells. |
hsa-miR-345 |
|
prostate cancer |
down |
MiR-345 suppresses proliferation, migration and invasion by targeting Smad1 in human prostate cancer. |
hsa-miR-34a |
|
prostate cancer |
down |
The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. |
hsa-miR-34a |
|
prostate cancer |
down |
MicroRNA-34a modulates c-Myc transcriptional complexes to suppress malignancy in human prostate cancer cells. |
hsa-miR-34a |
|
prostate cancer |
down |
LEF1 Targeting EMT in Prostate Cancer Invasion is Regulated by miR-34a. |
hsa-miR-34a |
|
prostate cancer |
down |
Registered report: the microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. |
hsa-miR-34b |
|
prostate cancer |
down |
miRNA-34b inhibits prostate cancer through demethylation, active chromatin modifications, and AKT pathways. |
hsa-miR-34c |
|
prostate cancer |
down |
miR-34c is downregulated in prostate cancer and exerts tumor suppressive functions. |
hsa-miR-374b |
|
prostate cancer |
down |
Global analysis of the differentially expressed miRNAs of prostate cancer in Chinese patients. |
hsa-miR-429 |
|
prostate cancer |
up |
Downregulation of microRNA-429 inhibits cell proliferation by targeting p27Kip1 in human prostate cancer cells. |
hsa-miR-449a |
|
prostate cancer |
down |
miR-449a targets HDAC-1 and induces growth arrest in prostate cancer. |
hsa-miR-449a |
|
prostate cancer |
down |
miR-449a causes Rb-dependent cell cycle arrest and senescence in prostate cancer cells. |
hsa-miR-4723-5p |
|
prostate cancer |
down |
MicroRNA-4723 Inhibits Prostate Cancer Growth through Inactivation of the Abelson Family of Nonreceptor Protein Tyrosine Kinases. |
hsa-miR-497 |
|
prostate cancer |
down |
MicroRNA-497 Suppresses Proliferation and Induces Apoptosis in Prostate Cancer Cells. |
hsa-miR-497 |
|
prostate cancer |
down |
Tumor-suppressive microRNA-497 targets IKK? to regulate NF-?B signaling pathway in human prostate cancer cells. |
hsa-miR-503 |
|
prostate cancer |
down |
miR-503 suppresses tumor cell proliferation and metastasis by directly targeting RNF31 in prostate cancer. |
hsa-miR-628-5p |
|
prostate cancer |
down |
Circulatory miR-628-5p is downregulated in prostate cancer patients. |
hsa-miR-642a-5p |
|
prostate cancer |
down |
Regulation of Expression of Deoxyhypusine Hydroxylase (DOHH), the Enzyme That Catalyzes the Activation of eIF5A, by miR-331-3p and miR-642-5p in Prostate Cancer Cells. |
hsa-miR-7 |
|
prostate cancer |
down |
MicroRNA-7 inhibits the stemness of prostate cancer stem-like cells and tumorigenesis by repressing KLF4/PI3K/Akt/p21 pathway. |
hsa-miR-765 |
|
prostate cancer |
down |
Hsa-miRNA-765 as a Key Mediator for Inhibiting Growth, Migration and Invasion in Fulvestrant-Treated Prostate Cancer. |
hsa-miR-940 |
|
prostate cancer |
down |
MicroRNA-940 suppresses prostate cancer migration and invasion by regulating MIEN1. |
hsa-miR-96 |
|
prostate cancer |
up |
miR-183-96-182 cluster is overexpressed in prostate tissue and regulates zinc homeostasis in prostate cells. |
hsa-miR-96 |
|
prostate cancer |
up |
miR-96 promotes cell proliferation and clonogenicity by down-regulating of FOXO1 in prostate cancer cells. |
hsa-miR-96 |
|
prostate cancer |
up |
Transforming growth factor-? promotes prostate bone metastasis through induction of microRNA-96 and activation of the mTOR pathway. |
hsa-miR-223 |
|
prostate cancer |
down |
Inhibiting inducible miR-223 further reduces viable cells in human cancer cell lines MCF-7 and PC3 treated by celastrol. |
hsa-miR-22 |
|
prostate cancer |
up |
Dual Action of miR-125b As a Tumor Suppressor and OncomiR-22 Promotes Prostate Cancer Tumorigenesis. |
hsa-miR-125b |
|
prostate cancer |
down |
Dual Action of miR-125b As a Tumor Suppressor and OncomiR-22 Promotes Prostate Cancer Tumorigenesis. |
hsa-miR-223 |
|
prostate cancer |
down |
Tumor-suppressive microRNA-223 inhibits cancer cell migration and invasion by targeting ITGA3/ITGB1 signaling in prostate cancer. |
hsa-miR-34a |
|
prostate cancer |
down |
Methylation-induced silencing of miR-34a enhances chemoresistance by directly upregulating ATG4B-induced autophagy through AMPK/mTOR pathway in prostate cancer. |
hsa-miR-573 |
|
prostate cancer |
down |
miR-573 inhibits prostate cancer metastasis by regulating epithelial-mesenchymal transition. |
hsa-miR-212 |
|
prostate cancer |
down |
MicroRNA-212 negatively regulates starvation induced autophagy in prostate cancer cells by inhibiting SIRT1 and is a modulator of angiogenesis and cellular senescence. |
hsa-miR-340 |
|
prostate cancer |
down |
microRNA-340 Suppresses Tumorigenic Potential of Prostate Cancer Cells by Targeting High-Mobility Group Nucleosome-Binding Domain 5. |
hsa-miR-378 |
|
prostate cancer |
down |
MiR-378 suppresses prostate cancer cell growth through downregulation of MAPK1 in vitro and in vivo. |
hsa-miR-301a |
|
prostate cancer |
up |
MiR-301a regulates E-cadherin expression and is predictive of prostate cancer recurrence. |
hsa-miR-26b |
|
prostate cancer |
down |
miR-26b inhibits autophagy by targeting ULK2 in prostate cancer cells. |
hsa-miR-135b |
|
prostate cancer |
down |
miR-135b inhibits tumour metastasis in prostate cancer by targeting STAT6. |
hsa-miR-24 |
|
prostate cancer |
down |
miR-24 regulates CDKN1B/p27 expression in prostate cancer. |
hsa-miR-421 |
|
prostate cancer |
down |
A transcriptional target of androgen receptor, miR-421 regulates proliferation and metabolism of prostate cancer cells. |
hsa-miR-301a |
|
prostate cancer |
up |
Hypoxia induced upregulation of miR-301a/b contributes to increased cell autophagy and viability of prostate cancer cells by targeting NDRG2. |
hsa-miR-301b |
|
prostate cancer |
up |
Hypoxia induced upregulation of miR-301a/b contributes to increased cell autophagy and viability of prostate cancer cells by targeting NDRG2. |
hsa-miR-103 |
|
prostate cancer |
down |
MicroRNA-103 suppresses tumor cell proliferation by targeting PDCD10 in prostate cancer. |
hsa-miR-141 |
|
prostate cancer |
up |
Exosomal microRNA-141 is upregulated in the serum of prostate cancer patients. |
hsa-miR-34a |
|
prostate cancer |
down |
miR-34a inhibits cell proliferation in prostate cancer by downregulation of SIRT1 expression. |
hsa-miR-340 |
|
prostate cancer |
down |
MicroRNA-340 inhibits prostate cancer cell proliferation and metastasis by targeting the MDM2-p53 pathway. |
hsa-miR-613 |
|
prostate cancer |
down |
MicroRNA-613 represses prostate cancer cell proliferation and invasion through targeting Frizzled7. |
hsa-miR-195 |
|
prostate cancer |
down |
miR-195 Inhibits EMT by Targeting FGF2 in Prostate Cancer Cells. |
hsa-miR-335 |
|
prostate cancer |
down |
MicroRNA-335 and -543 suppress bone metastasis in prostate cancer via targeting endothelial nitric oxide synthase. |
hsa-miR-543 |
|
prostate cancer |
down |
MicroRNA-335 and -543 suppress bone metastasis in prostate cancer via targeting endothelial nitric oxide synthase. |
hsa-miR-150 |
|
prostate cancer |
up |
MIR-150 promotes prostate cancer stem cell development via suppressing p27Kip1. |
hsa-miR-146b |
|
prostate cancer |
down |
MicroRNA-146b acts as a potential tumor suppressor in human prostate cancer. |
hsa-miR-503 |
|
prostate cancer |
down |
GATA3-driven expression of miR-503 inhibits prostate cancer progression by repressing ZNF217 expression. |
hsa-miR-1301 |
|
prostate cancer |
up |
miR-1301 promotes prostate cancer proliferation through directly targeting PPP2R2C. |
hsa-miR-129 |
|
prostate cancer |
down |
Downregulation of miR-129 in peripheral blood mononuclear cells is a diagnostic and prognostic biomarker in prostate cancer. |
hsa-miR-26a |
|
prostate cancer |
down |
MiR-26a and miR-138 block the G1/S transition by targeting the cell cycle regulating network in prostate cancer cells. |
hsa-miR-138 |
|
prostate cancer |
down |
MiR-26a and miR-138 block the G1/S transition by targeting the cell cycle regulating network in prostate cancer cells. |
hsa-miR-31 |
|
prostate cancer |
down |
Class I HDAC inhibitor mocetinostat induces apoptosis by activation of miR-31 expression and suppression of E2F6. |
hsa-miR-204-5p |
|
prostate cancer |
down |
Tumor suppressor miRNA-204-5p promotes apoptosis by targeting BCL2 in prostate cancer cells. |
hsa-miR-26a-5p |
|
prostate cancer |
down |
Loss of miR-26a-5p promotes proliferation, migration, and invasion in prostate cancer through negatively regulating SERBP1. |
hsa-miR-204 |
|
prostate cancer |
down |
The dual regulatory role of miR-204 in cancer. |
hsa-miR-22 |
|
prostate cancer |
down |
miR-22 inhibits tumor growth and metastasis by targeting ATP citrate lyase: evidence in osteosarcoma, prostate cancer, cervical cancer and lung cancer. |
hsa-miR-182-5p |
|
prostate cancer |
up |
Androgen receptor regulated microRNA miR-182-5p promotes prostate cancer progression by targeting the ARRDC3/ITGB4 pathway. |
hsa-miR-154-5p |
|
prostate cancer |
down |
miRNA-154-5p Inhibits Proliferation, Migration and Invasion by Targeting E2F5 in Prostate Cancer Cell Lines. |
hsa-miR-452 |
|
prostate cancer |
down |
Regulation of E3 ubiquitin ligase-1 (WWP1) by microRNA-452 inhibits cancer cell migration and invasion in prostate cancer. |
hsa-miR-539 |
|
prostate cancer |
down |
miR-539 inhibits prostate cancer progression by directly targeting SPAG5. |
hsa-miR-26a |
|
prostate cancer |
down |
Downregulated microRNA-26a modulates prostate cancer cell proliferation and apoptosis by targeting COX-2. |
hsa-miR-3619-5p |
|
prostate cancer |
down |
miR-3619-5p inhibits prostate cancer cell growth by activating CDKN1A expression. |
hsa-miR-486-5p |
|
prostate cancer |
down |
miR-486-5p suppresses prostate cancer metastasis by targeting Snail and regulating epithelial-mesenchymal transition. |
hsa-miR-146a |
|
prostate cancer |
down |
LncRNA PVT1 regulates prostate cancer cell growth by inducing the methylation of miR-146a. |
hsa-miR-382 |
|
prostate cancer |
down |
MicroRNA-382 inhibits prostate cancer cell proliferation and metastasis through targeting COUP-TFII. |
hsa-miR-1297 |
|
prostate cancer |
down |
MicroRNA-1297 inhibits prostate cancer cell proliferation and invasion by targeting the AEG-1/Wnt signaling pathway. |
hsa-miR-372 |
|
prostate cancer |
down |
microRNA-372 Suppresses Migration and Invasion by Targeting p65 in Human Prostate Cancer Cells. |
hsa-miR-186 |
|
prostate cancer |
down |
miR-186 inhibits cell proliferation of prostate cancer by targeting GOLPH3. |
hsa-miR-27a |
|
prostate cancer |
down |
Androgen-induced miR-27A acted as a tumor suppressor by targeting MAP2K4 and mediated prostate cancer progression. |
hsa-miR-509-5p |
|
prostate cancer |
down |
Inhibition of invasion and migration of prostate cancer cells by miRNA-509-5p via targeting MDM2. |
hsa-miR-543 |
|
prostate cancer |
up |
MiR-543 Promotes Proliferation and Epithelial-Mesenchymal Transition in Prostate Cancer via Targeting RKIP. |
hsa-miR-30d |
|
prostate cancer |
up |
MicroRNA-30d promotes angiogenesis and tumor growth via MYPT1/c-JUN/VEGFA pathway and predicts aggressive outcome in prostate cancer. |
hsa-miR-22 |
|
prostate cancer |
up |
MTA1-activated Epi-microRNA-22 regulates E-cadherin and prostate cancer invasiveness. |
hsa-miR-802 |
|
prostate cancer |
down |
microRNA-802 inhibits epithelial-mesenchymal transition through targeting flotillin-2 in human prostate cancer. |
hsa-miR-130b |
|
prostate cancer |
down |
Downregulation of miR-130b~301b cluster is mediated by aberrant promoter methylation and impairs cellular senescence in prostate cancer. |
hsa-miR-466 |
|
prostate cancer |
down |
MicroRNA-466 inhibits tumor growth and bone metastasis in prostate cancer by direct regulation of osteogenic transcription factor RUNX2. |
hsa-miR-1307 |
|
prostate cancer |
up |
miR-1307 promotes the proliferation of prostate cancer by targeting FOXO3A. |
hsa-miR-141 |
|
prostate cancer |
down |
MicroRNA-141 suppresses prostate cancer stem cells and metastasis by targeting a cohort of pro-metastasis genes. |
hsa-miR-744 |
|
prostate cancer |
up |
MicroRNA-744 promotes prostate cancer progression through aberrantly activating Wnt/?-catenin signaling. |
hsa-miR-218 |
|
prostate cancer |
down |
MicroRNA-218 inhibits tumor growth and increases chemosensitivity to CDDP treatment by targeting BCAT1 in prostate cancer. |
hsa-miR-34b-3p |
|
prostate cancer |
down |
Differential expression of miR-34b and androgen receptor pathway regulate prostate cancer aggressiveness between African-Americans and Caucasians. |
hsa-miR-218 |
|
prostate cancer |
down |
Tumor-suppressive microRNA-218 inhibits tumor angiogenesis via targeting the mTOR component RICTOR in prostate cancer. |
hsa-miR-194 |
|
prostate cancer |
up |
MicroRNA-194 Promotes Prostate Cancer Metastasis by Inhibiting SOCS2. |
hsa-miR-130a |
|
prostate cancer |
down |
Epigenetic Disruption of miR-130a Promotes Prostate Cancer By Targeting SEC23B and DEPDC1. |
hsa-miR-194 |
|
prostate cancer |
down |
MicroRNA-194 suppresses prostate cancer migration and invasion by downregulating human nuclear distribution protein. |
hsa-miR-141-3p |
|
prostate cancer |
up |
MiR-141-3p promotes prostate cancer cell proliferation through inhibiting kruppel-like factor-9 expression. |
hsa-miR-1271 |
|
prostate cancer |
down |
MiR-1271 Inhibits Cell Growth in Prostate Cancer by Targeting ERG. |
hsa-miR-101 |
|
prostate cancer |
down |
miR-101 Enhances Cisplatin-Induced DNA Damage Through Decreasing Nicotinamide Adenine Dinucleotide Phosphate Levels by Directly Repressing Tp53-Induced Glycolysis and Apoptosis Regulator Expression in |
hsa-miR-590-3p |
|
prostate cancer |
up |
MicroRNA-590-3p promotes cell proliferation and invasion by targeting inositol polyphosphate 4-phosphatase type II in human prostate cancer cells. |
hsa-miR-501-3p |
|
prostate cancer |
down |
Identification of non-invasive miRNAs biomarkers for prostate cancer by deep sequencing analysis of urinary exosomes. |
hsa-miR-196a-5p |
|
prostate cancer |
down |
Identification of non-invasive miRNAs biomarkers for prostate cancer by deep sequencing analysis of urinary exosomes. |
hsa-miR-588 |
|
prostate cancer |
up |
MicroRNA-588 is upregulated in human prostate cancer with prognostic and functional implications. |
hsa-miR-30e* |
|
prostate cancer |
up |
miR-30e* is overexpressed in prostate cancer and promotes NF-?B-mediated proliferation and tumor growth. |
hsa-miR-33a |
|
prostate cancer |
down |
miR-33a is a tumor suppressor microRNA that is decreased in prostate cancer. |
hsa-miR-618 |
|
prostate cancer |
down |
miR-618 Inhibits Prostate Cancer Migration and Invasion by Targeting FOXP2. |
hsa-miR-141 |
|
prostate cancer |
down |
Re: MicroRNA-141 Suppresses Prostate Cancer Stem Cells and Metastasis by Targeting a Cohort of Pro-Metastasis Genes. |
hsa-miR-483-5p |
|
prostate cancer |
up |
miR-483-5p promotes prostate cancer cell proliferation and invasion by targeting RBM5. |
hsa-miR-210-3p |
|
prostate cancer |
up |
Oncogenic miR-210-3p promotes prostate cancer cell EMT and bone metastasis via NF-?B signaling pathway. |
hsa-miR-30c |
|
prostate cancer |
down |
Low expression of microRNA-30c promotes prostate cancer cells invasion involved in downregulation of KRAS protein. |
hsa-miR-500 |
|
prostate cancer |
up |
Inhibition of microRNA-500 has anti-cancer effect through its conditional downstream target of TFPI in human prostate cancer. |
hsa-miR-186 |
|
prostate cancer |
down |
miRNA-186 inhibits prostate cancer cell proliferation and tumor growth by targeting YY1 and CDK6. |
hsa-let-7a |
|
prostate cancer |
down |
MiRNALet-7a mediates prostate cancer PC-3 cell invasion, migration by inducing epithelial-mesenchymal transition through CCR7/MAPK pathway. |
hsa-miR-204 |
|
prostate cancer |
down |
MiR-204 enhances mitochondrial apoptosis in doxorubicin-treated prostate cancer cells by targeting SIRT1/p53 pathway. |
hsa-miR-199a |
|
prostate cancer |
down |
MiR-199a suppresses prostate cancer paclitaxel resistance by targeting YES1. |
hsa-miR-141-3p |
|
prostate cancer |
down |
Downregulation of miR-141-3p promotes bone metastasis via activating NF-?B signaling in prostate cancer. |
hsa-miR-205-5p |
|
prostate cancer |
down |
Regulation of HMGB3 by antitumor miR-205-5p inhibits cancer cell aggressiveness and is involved in prostate cancer pathogenesis. |
hsa-miR-181a |
|
prostate cancer |
up |
MiR-181a promotes epithelial to mesenchymal transition of prostate cancer cells by targeting TGIF2. |
hsa-miR-20b |
|
prostate cancer |
up |
miR-20b promotes cellular proliferation and migration by directly regulating phosphatase and tensin homolog in prostate cancer. |
hsa-miR-193a-3p |
|
prostate cancer |
down |
MicroRNA-193a-3p inhibits cell proliferation in prostate cancer by targeting cyclin D1. |
hsa-miR-493-5p |
|
prostate cancer |
down |
c-Met, CREB1 and EGFR are involved in miR-493-5p inhibition of EMT via AKT/GSK-3?/Snail signaling in prostate cancer. |
hsa-miR-323 |
|
prostate cancer |
up |
microRNA-323 upregulation promotes prostate cancer growth and docetaxel resistance by repressing p73. |
hsa-miR-454 |
|
prostate cancer |
up |
Suppression of microRNA-454 impedes the proliferation and invasion of prostate cancer cells by promoting N-myc downstream-regulated gene 2 and inhibiting WNT/?-catenin signaling. |
hsa-miR-486-5p |
|
prostate cancer |
up |
The miR-486-5p plays a causative role in prostate cancer through negative regulation of multiple tumor suppressor pathways. |
hsa-miR-129 |
|
prostate cancer |
down |
MiR-129 inhibits cell proliferation and metastasis by targeting ETS1 via PI3K/AKT/mTOR pathway in prostate cancer. |
hsa-miR-34a |
|
prostate cancer |
down |
miR-34a Regulates Expression of the Stathmin-1 Oncoprotein and Prostate Cancer Progression. |
hsa-miR-615 |
|
prostate cancer |
down |
MiR-615 inhibits prostate cancer cell proliferation and invasion by directly targeting Cyclin D2. |
hsa-miR-1246 |
|
prostate cancer |
down |
microRNA-1246 Is an Exosomal Biomarker for Aggressive Prostate Cancer. |
hsa-miR-493-3p |
|
prostate cancer |
down |
Downregulation of N6-methyladenosine binding YTHDF2 protein mediated by miR-493-3p suppresses prostate cancer by elevating N6-methyladenosine levels. |
hsa-miR-195 |
|
prostate cancer |
down |
miR-195 inhibits cell proliferation and angiogenesis in human prostate cancer by downregulating PRR11 expression. |
hsa-miR-132 |
|
prostate cancer |
down |
Identification of tumor suppressive role of microRNA-132 and its target gene in tumorigenesis of prostate cancer. |
hsa-miR-203 |
|
prostate cancer |
down |
The miR-203/SNAI2 axis regulates prostate tumor growth, migration, angiogenesis and stemness potentially by modulating GSK-3?/?-CATENIN signal pathway. |
hsa-miR-503 |
|
prostate cancer |
down |
microRNA-503 suppresses the migration, proliferation and colony formation of prostate cancer cells by targeting tumor protein D52 like 2. |
hsa-miR-1301-3p |
|
prostate cancer |
up |
miR-1301-3p promotes prostate cancer stem cell expansion by targeting SFRP1 and GSK3?. |
hsa-miR-671 |
|
prostate cancer |
up |
miR-671 promotes prostate cancer cell proliferation by targeting tumor suppressor SOX6. |
hsa-miR-182 |
|
prostate cancer |
up |
MiR-182 promotes prostate cancer progression through activating Wnt/?-catenin signal pathway. |
hsa-miR-301a |
|
prostate cancer |
up |
Hyperglycaemia-induced miR-301a promotes cell proliferation by repressing p21 and Smad4 in prostate cancer. |
hsa-miR-141 |
|
prostate cancer |
down |
miR-141 inhibits prostatic cancer cell proliferation and migration, and induces cell apoptosis via targeting of RUNX1. |
hsa-miR-133b |
|
prostate cancer |
down |
Posttranscriptional Regulation of Human Antigen R by miR-133b Enhances Docetaxel Cytotoxicity Through the Inhibition of ATP-Binding Cassette Subfamily G Member 2 in Prostate Cancer Cells. |
hsa-miR-491-5p |
|
prostate cancer |
down |
MiR-491-5p negatively regulates cell proliferation and motility by targeting PDGFRA in prostate cancer. |
hsa-miR-143 |
|
prostate cancer |
down |
Insulin-like growth factor-I induces chemoresistence to docetaxel by inhibiting miR-143 in human prostate cancer. |
hsa-miR-185-5p |
|
prostate cancer |
down |
Downregulation of miR-1266-5P, miR-185-5P and miR-30c-2 in prostatic cancer tissue and cell lines. |
hsa-miR-1266-5p |
|
prostate cancer |
down |
Downregulation of miR-1266-5P, miR-185-5P and miR-30c-2 in prostatic cancer tissue and cell lines. |
hsa-miR-126 |
|
prostate cancer |
down |
MicroRNA-126 inhibits proliferation and metastasis in prostate cancer via regulation of ADAM9. |
hsa-miR-206 |
|
prostate cancer |
up |
MicroRNA-206 regulates the epithelial-mesenchymal transition and inhibits the invasion and metastasis of prostate cancer cells by targeting Annexin A2. |
hsa-miR-191 |
|
prostate cancer |
up |
Upregulation of miR-191 promotes cell growth and invasion via targeting TIMP3 in prostate cancer. |
hsa-miR-1 |
|
prostate cancer |
down |
Cell-type specific expression of oncogenic and tumor suppressive microRNAs in the human prostate and prostate cancer. |
hsa-miR-143 |
|
prostate cancer |
down |
Cell-type specific expression of oncogenic and tumor suppressive microRNAs in the human prostate and prostate cancer. |
hsa-miR-141 |
|
prostate cancer |
up |
Cell-type specific expression of oncogenic and tumor suppressive microRNAs in the human prostate and prostate cancer. |
hsa-miR-21 |
|
prostate cancer |
up |
Cell-type specific expression of oncogenic and tumor suppressive microRNAs in the human prostate and prostate cancer. |
hsa-miR-152 |
|
prostate cancer |
down |
[Circulating miR-152 helps early prediction of postoperative biochemical recurrence of prostate cancer]. |
hsa-miR-652 |
|
prostate cancer |
up |
MicroRNA-652 induces NED in LNCaP and EMT in PC3 prostate cancer cells. |
hsa-miR-29c |
|
prostate cancer |
down |
Up-regulated miR-29c inhibits cell proliferation and glycolysis by inhibiting SLC2A3 expression in prostate cancer. |
hsa-miR-152-3p |
|
prostate cancer |
up |
A Plasma Biomarker Panel of Four MicroRNAs for the Diagnosis of Prostate Cancer. |
hsa-miR-17 |
|
prostate cancer |
down |
MiR-17 Regulates Prostate Cancer Cell Proliferation and Apoptosis Through Inhibiting JAK-STAT3 Signaling Pathway. |
hsa-miR-452-5p |
|
prostate cancer |
down |
Role of miR-452-5p in the tumorigenesis of prostate cancer: A study based on the Cancer Genome Atl(TCGA), Gene Expression Omnibus (GEO), and bioinformatics analysis. |
hsa-miR-206 |
|
prostate cancer |
down |
MiR-206 inhibits proliferation and migration of prostate cancer cells by targeting CXCL11. |
hsa-miR-1180 |
|
prostate cancer |
down |
MicroRNA-1180 is associated with growth and apoptosis in prostate cancer via TNF receptor associated factor 1 expression regulation and nuclear factor-?B signaling pathway activation. |
hsa-miR-211 |
|
prostate cancer |
down |
MicroRNA-211 suppresses prostate cancer proliferation by targeting SPARC. |
hsa-miR-144-3p |
|
prostate cancer |
down |
MicroRNA-144-3p inhibits cell proliferation and induces cell apoptosis in prostate cancer by targeting CEP55. |
hsa-miR-146b |
|
prostate cancer |
up |
MiR-146b inhibits autophagy in prostate cancer by targeting the PTEN/Akt/mTOR signaling pathway. |
hsa-miR-1266-5p |
|
prostate cancer |
down |
miR-1266-5p and miR-185-5p Promote Cell Apoptosis in Human Prostate Cancer Cell Lines |
hsa-miR-185-5p |
|
prostate cancer |
down |
miR-1266-5p and miR-185-5p Promote Cell Apoptosis in Human Prostate Cancer Cell Lines |
hsa-miR-202 |
|
prostate cancer |
down |
miR-202 suppresses prostate cancer growth and metastasis by targeting PIK3CA. |
hsa-miR-133a-3p |
|
prostate cancer |
down |
Downregulation of miR-133a-3p promotes prostate cancer bone metastasis via activating PI3K/AKT signaling. |
hsa-miR-205-5p |
|
prostate cancer |
down |
miR-205-5p inhibits cell migration and invasion in prostatic carcinoma by targeting ZEB1. |
hsa-miR-99a |
|
prostate cancer |
down |
Expression of microRNA-99a-3p in Prostate Cancer Based on Bioinformatics Data and Meta-Analysis of a Literature Review of 965 Cases. |
hsa-miR-410-3p |
|
prostate cancer |
down |
miR-410-3p promotes prostate cancer progression via regulating PTEN/AKT/mTOR signaling pathway. |
hsa-miR-139-5p |
|
prostate cancer |
down |
MicroRNA-139-5P inhibits human prostate cancer cell proliferation by targeting Notch1. |
hsa-miR-519d |
|
prostate cancer |
down |
MiR-519d inhibits prostate cancer cell proliferation, cycle and invasion via targeting NRBP1. |
hsa-miR-1 |
|
prostate cancer |
down |
Overexpression of MicroRNA-1 in Prostate Cancer Cells Modulates the Blood Vessel System of an In Vivo Hen's Egg Test-Chorioallantoic Membrane Model. |
hsa-miR-150 |
|
prostate cancer |
down |
MicroRNA-150 suppresses epithelial-mesenchymal transition, invasion, and metastasis in prostate cancer through the TRPM4-mediated ?-catenin signaling pathway. |
hsa-miR-139-5p |
|
prostate cancer |
down |
Downregulation of miR-139-5p promotes prostate cancer progression through regulation of SOX5. |
hsa-miR-1 |
|
prostate cancer |
down |
MiR-1 inhibits prostate cancer PC3 cells proliferation through the Akt/mTOR signaling pathway by binding to c-Met. |
hsa-miR-192 |
|
prostate cancer |
up |
miR-192 Is Overexpressed and Promotes Cell Proliferation in Prostate Cancer. |
hsa-miR-93 |
|
prostate cancer |
up |
Molecular mechanism and role of microRNA-93 in human cancers: A study based on bioinformatics analysis, meta-analysis, and quantitative polymerase chain reaction validation. |
hsa-miR-373-3p |
|
prostate cancer |
down |
MicroRNA-373-3p inhibits prostate cancer progression by targeting AKT1. |
hsa-miR-10a |
|
prostate cancer |
down |
MiR-10a functions as a tumor suppressor in prostate cancer via targeting KDM4A. |
hsa-miR-221 |
|
prostate cancer |
up |
The correlation between microRNA-221/222 cluster overexpression and malignancy: an updated meta-analysis including 2693 patients. |
hsa-miR-222 |
|
prostate cancer |
up |
The correlation between microRNA-221/222 cluster overexpression and malignancy: an updated meta-analysis including 2693 patients. |